Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Terri Matson"'
Autor:
Kathleen B. Cartmell, Heather S. Bonilha, Terri Matson, Debbie C. Bryant, Jane Zapka, Tricia A. Bentz, Marvella E. Ford, Chanita Hughes-Halbert, Kit N. Simpson, Anthony J. Alberg
Publikováno v:
Contemporary Clinical Trials Communications, Vol 3, Iss C, Pp 86-93 (2016)
Background: Clinical trials (CT) represent an important treatment option for cancer patients. Unfortunately, patients face challenges to enrolling in CTs, such as logistical barriers, poor CT understanding and complex clinical regimens. Patient navig
Externí odkaz:
https://doaj.org/article/004c928e46cd47dea64fbaee51547371
Autor:
Elizabeth Garrett-Mayer, Robert K. Stuart, Luciano J. Costa, Jagadish Kummetha Venkata, Kiwana Gibbs, Woodrow J. Coker, Besim Ogretmen, Jin H. Song, Yubin Kang, Zhuang Wan, Houjian Cai, Terri Matson, Ningfei An, Charles D. Smith
Publikováno v:
Blood. 124:1915-1925
Sphingolipid metabolism is being increasingly recognized as a key pathway in regulating cancer cell survival and proliferation. However, very little is known about its role in multiple myeloma (MM). We investigated the potential of targeting sphingos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ac637594c63e9a5d40d2b93662967dc
https://doi.org/10.1182/blood-2014-03-559385
https://doi.org/10.1182/blood-2014-03-559385
Autor:
Terri Matson, Yubin Kang, Houjian Cai, Woodrow J. Coker, Luciano J. Costa, Kiwana Gibbs, Jin Song, Jagadish Kummetha Venkata, Robert K. Stuart, Ningfei An, Charles D. Smith
Publikováno v:
Blood. 122:3163-3163
Introduction Multiple Myeloma (MM) is the second most common hematological malignancy in the United States and accounts for ∼10,600 deaths annually. MM remains an incurable disease and almost all patients will eventually relapse and become refracto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::123c57c44cb9c588e80e911d5a58ac58
https://doi.org/10.1182/blood.v122.21.3163.3163
https://doi.org/10.1182/blood.v122.21.3163.3163
Autor:
Yan Zhuang, Terri Matson, Susan L. Cusack, Charles D. Smith, Carolyn D. Britten, Elizabeth Garrett-Mayer, Steve H. Chin, Lynn W. Maines, Melanie B. Thomas, Alan Brisendine, Tricia A. Bentz
Publikováno v:
Molecular Cancer Therapeutics. 12:C62-C62
Sphingosine kinases (SK1 and SK2) are new potential targets for anticancer drugs because SK inhibitors elevate ceramide levels thereby promoting apoptosis of tumor cells, and concomitantly reduce sphingosine 1-phosphate (S1P) levels thereby attenuati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::efa9aefa0480a1a7e79662e6613594c4
https://doi.org/10.1158/1535-7163.targ-13-c62
https://doi.org/10.1158/1535-7163.targ-13-c62
Autor:
Debbie C. Bryant, Kit N. Simpson, Terri Matson, Chanita Hughes-Halbert, Kathleen B. Cartmell, Marvella E. Ford, Heather Shaw Bonilha, Jane G. Zapka, Anthony J. Alberg, Tricia A. Bentz
Publikováno v:
Contemporary Clinical Trials Communications, Vol 3, Iss C, Pp 86-93 (2016)
Contemporary Clinical Trials Communications
Contemporary Clinical Trials Communications
Background Clinical trials (CT) represent an important treatment option for cancer patients. Unfortunately, patients face challenges to enrolling in CTs, such as logistical barriers, poor CT understanding and complex clinical regimens. Patient naviga
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5fb6186971d0b8de044c757977293b5c